Literature DB >> 8792602

Amniotic fluid polarization of fluorescence and lecithin/sphingomyelin ratio decision criteria assessed.

L H Bernstein1, R Stiller, C Menzies, M McKenzie, C Rundell.   

Abstract

A negative finding of amniotic fluid (AF) phosphatidyl glycerol (PG) does not eliminate the need for determining the lecithin/sphingomyelin ratio (LSR). We use a novel approach to classify fetal lung maturity (FLM) data, and to validate the fluorescence polarization (FP) surfactant assay (Abbott), which replaces the PG assay and reduces the frequency of repeat LSR. This method finds the values (decision points) of these tests that allow for classifying the data with least errors. These tests best identify the risk of respiratory distress syndrome (RDS) from fetal lung immaturity. We find the decision values for tests by exploring the data for information content and optimize their selection using group-based reference. We previously defined normal reference as the maximum entropy set with no information. The uncertainty resolved by information provided in the data allows formation of syndromic classes. This is greatest at the values for the variables (decision-points) associated with the greatest decrease in entropy. Decision-values found for PF, EGA, PG, LSR that classify amniotic fluids into the mature and not-mature classes are in agreement with the results of ROC analysis. We validate the replacement of PG by the PF method. We also find a level of FP below which LSR might be required to resolve uncertainty and above which the FP indicates maturity. We confirm the ability to evaluate fetal maturity methods using information analysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8792602      PMCID: PMC2588960     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  13 in total

1.  Hypocholesterolemia as a predictor of death: a prospective study of 224 nursing home residents.

Authors:  R B Verdery; A P Goldberg
Journal:  J Gerontol       Date:  1991-05

2.  The utility of the TDx test in the assessment of fetal lung maturity.

Authors:  J D Steinfeld; P Samuels; M A Bulley; A W Cohen; D B Goodman; M B Senior
Journal:  Obstet Gynecol       Date:  1992-03       Impact factor: 7.661

3.  Usefulness of data on albumin and prealbumin concentrations in determining effectiveness of nutritional support.

Authors:  L H Bernstein; C J Leukhardt-Fairfield; W Pleban; R Rudolph
Journal:  Clin Chem       Date:  1989-02       Impact factor: 8.327

4.  Improved fluorescence polarization assay for use in evaluating fetal lung maturity. II. Analytical evaluation and comparison with the lecithin/sphingomyelin ratio.

Authors:  C A Foerder; J F Tait; R W Franklin; E R Ashwood
Journal:  Clin Chem       Date:  1986-02       Impact factor: 8.327

5.  Determination of malnutrition in hospitalized patients with the use of a group-based reference.

Authors:  A M Spiekerman; R A Rudolph; L H Bernstein
Journal:  Arch Pathol Lab Med       Date:  1993-02       Impact factor: 5.534

6.  A predictive model for fetal lung maturity employing gestational age and test results.

Authors:  M J Tanasijevic; D R Wybenga; D Richardson; M F Greene; R Lopez; J W Winkelman
Journal:  Am J Clin Pathol       Date:  1994-12       Impact factor: 2.493

7.  Medically significant concentrations of prostate-specific antigen in serum assessed.

Authors:  L H Bernstein; R A Rudolph; M M Pinto; N Viner; H Zuckerman
Journal:  Clin Chem       Date:  1990-03       Impact factor: 8.327

8.  Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.

Authors:  K S Albain; J J Crowley; M LeBlanc; R B Livingston
Journal:  J Clin Oncol       Date:  1991-09       Impact factor: 44.544

9.  Small-cell carcinoma of the lung: derivation of a prognostic staging system.

Authors:  U Sagman; E Maki; W K Evans; D Warr; F A Shepherd; J P Sculier; R Haddad; D Payne; J F Pringle; J L Yeoh
Journal:  J Clin Oncol       Date:  1991-09       Impact factor: 44.544

10.  Enzymatic measurement of phosphatidylglycerol in amniotic fluid.

Authors:  G W Jones; E R Ashwood
Journal:  Clin Chem       Date:  1994-04       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.